Skip to main content
WGS
NASDAQ Life Sciences

GeneDx Slides Premarket as Q4 Revenue Outlook Lands Well Below Consensus

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$58
Mkt Cap
$1.96B
52W Low
$32.21
52W High
$170.87
52W Position info
80% above low
Off High info
66% below high
Rel. Volume info
2.5× avg
Market data snapshot near publication time

WGS sits 80% above its 52-week low of $32.21 on elevated volume (2.5× avg).

Summary

GeneDx guided Q4 adjusted revenue to about $135M, roughly $7.6M below the $142.6M FactSet consensus, and the stock fell in premarket trading. Q3 itself was mixed: revenue of $123.1M edged past consensus by about $0.2M with 5% year-over-year growth, but the GAAP loss per share of $0.41 missed by $0.03 and the net loss widened about 62% to $12.3M. Gross margin slipped to roughly 70% from about 72% a year ago, even as exome and genome test revenue grew about 12% to $110.4M. The company reiterated its full-year revenue outlook of $475M-$490M, so the soft Q4 guide implies the growth deceleration is back-end loaded rather than a cut to the annual range. The setup matters because GeneDx is still burning cash — the Q3 10-Q showed $72.0M of nine-month operating cash burn against $170.1M of liquidity — so a slower revenue ramp pressures the path to sustained profitability.

At the time of this announcement, WGS was trading at $58.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $32.21 to $170.87. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

WGS - Latest Insights

WGS
Nov 09, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $59.00
Real-time Price: $51.87 info
Change: -$7.13 (-12%) info
Market Cap: $1.555B info
WGS
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $65.65
Real-time Price: $51.87 info
Change: -$13.78 (-21%) info
Market Cap: $1.555B info
WGS
Aug 03, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.01
Real-time Price: $51.87 info
Change: -$25.14 (-33%) info
Market Cap: $1.555B info
WGS
Aug 03, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $62.47
Real-time Price: $51.87 info
Change: -$10.60 (-17%) info
Market Cap: $1.555B info
WGS
Aug 03, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $60.19
Real-time Price: $51.87 info
Change: -$8.32 (-14%) info
Market Cap: $1.555B info